Skip to main content
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

News releases

May 2016arrow

Miglioretti awarded $7.5 million to evaluate supplemental breast imaging

May 25, 2016

Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density.

National Cancer Institute re-designates the cancer center

May 17, 2016

The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.

Autism and cancer share a remarkable number of risk genes in common

May 3, 2016

Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.

Common supplement boosts kidney cancer therapy

May 2, 2016

Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics.

Targeted hepatitis B virus screening effective in addressing infection, liver disease risk

May 2, 2016

A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.

April 2016arrow

SU2C awards Albeck Innovative Research Grant

April 26, 2016

UC Davis molecular biologist John Albeck is among 10 recipients chosen to receive a 2016 Innovative Research Grant (IRG) from Stand Up to Cancer (SU2C), a non-profit that supports innovative, high-risk, high-reward projects to accelerate the pace of cancer research and give patients access to new therapies as quickly as possible.

UC Davis Comprehensive Cancer Center earns new quality certification

April 20, 2016

The UC Davis Comprehensive Cancer Center’s Division of Hematology/Oncology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting the nation’s highest quality standards for cancer care.

UC Davis expands surgical care for lower GI diseases

April 20, 2016

Linda Farkas, a surgeon and expert in hereditary cancers, has joined UC Davis Health System as a professor of surgery and chief of the newly created Division of Colon and Rectal Surgery.

International Cancer Genome Consortium for Medicine launch announced

April 17, 2016

The International Cancer Genome Consortium (ICGC) today announced plans to launch of the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the consortium’s evolution that will link genomics to clinical information and health.

Radiation improves survival in older patients with soft tissue sarcomas

April 11, 2016

UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS).

March 2016arrow

New target makes end run against therapy-resistant prostate cancer

March 28, 2016

Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth.

State stem cell agency approves research funding for UC Davis scientists

March 21, 2016

Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM).

February 2016arrow

Two UC Davis pediatric oncology patients meet princesses at Disney on Ice

February 24, 2016

Two UC Davis Children’s Hospital and UC Davis Comprehensive Cancer Center patients had the chance to forget about cancer treatments for an evening and meet Princess Anna and Princess Elsa from Frozen at recent Disney On Ice performances. 

"Coloring therapy" helps ease patients' stress

February 24, 2016

Sandy Gantt receives infusions of chemotherapy to treat her leukemia for hours on end, day after day. But she’s found one thing that transports her from that reality to a less stressful place.

Patient coordinator to go bald to help kids with cancer

February 24, 2016

It can’t be easy parting with a head of beautiful long, dark hair. But that’s exactly what Venessa Garcia plans to do. A patient care coordinator at UC Davis Comprehensive Cancer Center, Garcia will undergo the razor treatment March 14 during the annual St. Baldrick’s Foundation event for pediatric cancer research.

Finding new targets to battle drug resistance

February 1, 2016

Researchers at UC Davis and Lawrence Livermore and Los Alamos national laboratories have created a chemotherapy-resistant line of bladder cancer cells to study how tumors become resistant to chemotherapy and identified molecular changes that could drive that resistance.

January 2016arrow

Young, poor African Americans and Hispanics have harder time beating Hodgkin Lymphoma

January 29, 2016

African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found.

Melnikow appointed to expert panel of the Institute for Clinical and Economic Review

January 22, 2016

UC Davis physician and health policy expert Joy Melnikow has been appointed to the panel of the California Technology Assessment Forum of the Institute for Clinical and Economic Review.

More research needed on evaluation of dense breasts

January 11, 2016

A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next.

Making a safe procedure even safer

January 11, 2016

In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women.

Women recognize UC Davis as one of America's best hospitals for bariatric surgery, cancer and heart care

January 8, 2016

UC Davis Medical Center has received the 2016 Women’s Choice Award as one of America’s best hospitals for bariatric surgery, cancer and heart care.

December 2015arrow

It takes a UC village: Smoking cessation push goes high tech

December 23, 2015

Buster Halcomb was just 5, a scruffy shoeshine boy in a billiard hall in Cumberland, Ky., when three men approached with packs of “tailor-made” cigarettes.

A visit to the gas station: Protein helps power up DNA repair

December 3, 2015

In a game-changing study, researchers at UC Davis and other organizations have shown that the enzyme cyclin-dependent kinase 1 (CDK1), which plays a key role in DNA repair, also leaves the nucleus to boost cellular energy production. By irradiating normal cells, the team showed that CDK1 turned up production of ATP, cellular energy packets that – in this case – provided the necessary power supply to fix the radiation-damaged DNA.

November 2015arrow

Lam receives $4 million in NIH grants for novel cancer research

November 18, 2015

Kit Lam, professor and chair of the Department of Biochemistry and Molecular Medicine, has been awarded two major, multi-disciplinary U01 grants from the National Institutes of Health (NIH), the first to investigate use of a new tool to visualize cancer tumor growth and response to nanoparticle drugs, and the other to develop a new 4-D imaging tool to advance the understanding of how the nucleus functions in living cells.

Small RNA has big impact on prostate cancer

November 17, 2015

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.

Kelly takes the reins of prestigious SWOG Lung Committee

November 4, 2015

Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.

October 2015arrow

Renowned genomics researcher joins UC Davis Comprehensive Cancer Center

October 22, 2015

John D. McPherson, a basic scientist whose work contributed significantly to the sequencing of the human genome, has assumed the role of associate director, basic sciences at the UC Davis Comprehensive Cancer Center and holds the Auburn Community Cancer Endowed Chair in Basic Science.

Menopausal status a better indicator than age for mammography frequency

October 20, 2015

In a study conducted to inform American Cancer Society breast cancer screening guidelines, UC Davis researcher Diana L. Miglioretti reports a screening mammogram once every two years is safe for postmenopausal women at average risk of breast cancer.

UC Davis granted $15.5 million to build world's first total-body PET scanner

October 6, 2015

A UC Davis research team has been awarded $15.5 million to build the world’s first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation’s leading edge of molecular imaging.

September 2015arrow

New treatments a big step for patients with advanced kidney cancer

September 29, 2015

In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.

UC Davis researcher advocates ending Medicare coverage of controversial mammography tool

September 28, 2015

A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher in an editorial published online today in the Journal of the American Medical Association Internal Medicine.

Tumor suppressor LRIG1 controls breast cancer aggression and invasion

September 21, 2015

Researchers at UC Davis have shown that the protein LRIG1 reduces breast cancer invasion and could potentially help control metastasis. Using aggressive basal-like breast cancer cell lines, the scientists found that restoring LRIG1 expression reduced these cells’ growth and invasiveness.

Cancer Center joins collaborative molecular oncology intiative

September 15, 2015

The UC Davis Comprehensive Cancer Center has joined a unique new collaboration to accelerate the development of precision cancer treatment through the collection and sharing of genomics data

UC Davis patients, nurses star in new pediatric cancer video series

September 9, 2015

Children undergoing cancer treatment at UC Davis Comprehensive Cancer Center take center stage in a series of specially created videos aimed at helping families cope with a new diagnosis, through their treatment journey and into survivorship.

August 2015arrow

UC Davis team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can “paralyze” CD4 T cells, immune components that help orchestrate the body’s response to pathogens and other invaders.

UC Davis to employ canines to sniff out cancer

August 17, 2015

UC Davis clinicians are hoping to greatly advance cancer screenings with the innate olfactory skills of man’s best friend.

A better way to personalize bladder cancer treatments

August 13, 2015

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.

New combination treatment effective against melanoma skin metastases

August 11, 2015

mIn findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.

UC Davis cancer patient makes generous gift to ease children's hospital stay

August 7, 2015

In a check presentation Aug. 6 at the UC Davis Medical Center, Roy Chavez, a UC Davis brain cancer patient and Mule Creek State Prison correctional officer, made a generous gift to support programs and services for children staying at UC Davis Children’s Hospital.

Cherry lands top NCI grant

August 6, 2015

Simon Cherry, distinguished professor in the departments of Biomedical Engineering and Radiology, and co-leader of the UC Davis Comprehensive Cancer Center’s Biomedical Technology Program, has been selected to receive a prestigious Outstanding Investigator Award from the National Cancer Institute (NCI).

Long-term ovarian cancer survival higher than thought

August 5, 2015

Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.

July 2015arrow

UC Davis researchers awarded grant for HIV clinical trial using stem cells

July 23, 2015

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved funding a UC Davis Health System research team to conduct a clinical trial using bioengineered stem cells to treat HIV patients suffering from lymphoma, one of the deadly conditions associated with the disease.

One of America's top hospitals

July 21, 2015

UC Davis medical Center has again ranked as one of the best hospitals in the U.S. for 2015-16 in 10 adult medical specialties by U.S. News & World Report.

Radiation Oncology faculty earn key leadership roles

July 10, 2015

Two faculty members of the UC Davis Department of Radiation Oncology have been recognized for their leadership and expertise in cancer research and care.

UC Davis researchers find key mechanism that causes neuropathic pain

July 6, 2015

Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage.

June 2015arrow

Knoepfler awarded childhood cancer research grant

June 25, 2015

UC Davis stem cell scientist Paul Knoepfler has been awarded $250,000 for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.

Leiserowitz receives WAGO award

June 15, 2015

Gary Leiserowitz, chief of gynecologic oncology and interim chair of the Department of Obstetrics and Gynecology, received the Western Association of Gynecologic Oncologists (WAGO) James F. Nolan Award June 12 at the 2015 Annual Meeting in Santa Rosa.

UC Davis Division of Pediatric Hematology-Oncology welcomes new chief

June 15, 2015

Marcio H. Malogolowkin, an international leader in the treatment of rare pediatric liver tumors, has joined UC Davis as the new chief of the UC Davis Division of Pediatric Hematology and Oncology.